The company focuses on designing and manufacturing spinal implants using its proprietary Atipore™ technology platform. These implants are made from a porous biomaterial derived from nitinol technology, allowing for rapid bone cell growth and attachment without the need for bone grafting or cement. Biorthex's goal is to provide the surgical community with safe and technologically advanced spinal implants for the treatment of spinal disorders, diseases, and injuries. Additionally, the company is expanding its technology platform to further enhance its product offerings.